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Rapport de synthèse 
Valeur de la tomographie par émission de positons pour la résection de la paroi 
thoracique pour des tumeurs 
Les tumeurs de la paroi thoracique sont des pathologies graves dont le traitement principal 
consiste en une résection chirurgicale. L'enjeu majeur de cette intervention oncologique est de 
réséquer la totalité de la tumeur, ce qui nécessite une planification préopératoire minutieuse. 
Classiquement, l'identification et la localisation de la tumeur se fait à l'aide de la 
tomodensitométrie (computed tomography, CT) ou de l'imagerie par résonnance magnétique 
(IRM). Actuellement, l'imagerie nucléaire fonctionnelle par tomographie par émission de 
positons (positron emission tomography, PET) qui peut être couplée au CT (PET/CT) est de 
plus en plus appliquée aux patients présentant une tumeur maligne. Son efficacité a 
fréquemment été démontrée. 
Le but de la présente étude est d'évaluer la valeur du PET dans la planification de la résection 
des tumeurs de la paroi thoracique. Une analyse rétrospective de dix-huit patients opérés entre 
2004 et 2006 a été réalisée. Dans ce groupe de patient, la taille de la tumeur mesurée sur la 
pièce opératoire réséquée a été comparée à la taille de la tumeur mesurée sur le CT et le PET. 
Les résultats démontrent que le CT surestimait de manière consistante la taille réelle de la 
tumeur par rapport au PET (+64% par rapport à+ 1 %, P<0.001). De plus, le PET s'est avéré 
particulièrement performant pour prédire la taille des tumeurs de plus de 5 .5 cm de diamètre 
par rapport au CT (valeur prédictive positive 80% par rapport à 44% et spécificité 93% par 
apport à 64%, respectivement). 
Cette étude démontre que le PET permettrait de mesurer la taille des tumeurs de la paroi 
thoracique de manière plus précise que le CT. Cette nouvelle modalité diagnostique 
s'avèrerait donc utile pour planifier les résections chirurgicales de telles tumeurs. A notre 
connaissance, aucune publication ne décrit la valeur du PET dans ce domaine. Les 
performances accrues du PET permettraient une meilleure délimitation des tumeurs ce qui 
améliorerait la précision de la résection chirurgicale. 
En conclusion, cette étude préliminaire rétrospective démontre la faisabilité du PET pour les 
tumeurs de la paroi thoracique. Ces résultats devraient être confirmés par une étude 
prospective incluant un plus grand nombre de patients avec la perspective de juger l'impact 
clinique réel du PET sur la prise en charge thérapeutique des patients. 
2 
doi:10.151 O/icvts.2009.207621 
INTERACTIVE 
CARDIOVASCUlARAND 
THORAC!C SURGERY 
Interactive CardioVascular and Thoracic Surgery 9 (2009) 406-410 
www.icvts.org 
1 nstitutional report - Thoracic oncologie 
Value of positron emission tomography in full-thickness chest wall 
resections for mal ignancies* 
David Petermanna,*, Gilles Allenbachb, Sabine Schmidtc, Igor Letovanecd, Michel Christodouloua, 
Angelika Bischof Delaloyeb, Hans-Beat Risa, John O. Priorb, 1 
'Divisions of Thoracic and Vascular Surgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, CH-1011 Lausanne, Switzerland 
bDepartment of Nuclear Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland 
0Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland 
'Department of Pathology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland 
Received 17 March 2009; received in revised form 13 May 2009; accepted 18 May 2009 
Abstract 
Preoperative imaging for resection of chest wall malignancies is generally performed by computed tomography (CT). We evaluated the 
role of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in planning fulHhickness chest wall resections for malignancies. 
We retrospectively included 18 consecutive patients operated from 2004 to 2006 atour institution. Tumor extent was measured by CT and 
PET, using the two largest perpendicular tumor extensions in the chest wall plane to compute the tumor surface assuming an elliptical 
shape. lmaging measurements were compared to histopathology assessment of tumor borders. CT assessment consistently overestimated 
the tumor size as compared to PET (+64% vs. +1%, P<0.001). Moreover, PET was significantly better than CT at defining the size of 
lesions >24 cm2 corresponding to a mean diameter >5.5 cm or an ellipse of >4 cmx7.6 cm (positive predictive value 80% vs. 44% and 
specificity 93% vs. 64%, respectively). Metabolic PET imaging was superior to CT for defining the extent of chest wall tumors, particularly 
for tumors with a diameter > 5.5 cm. PET can complement CT in planning fulHhickness chest wall resection for malignancies, but its true 
value remains to be determined in larger, prospective studies. 
© 2009 Published by European Association for Cardio-Thoracic Surgery. All rights reserved. 
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1. Introduction 
Full-thickness chest wall resection is a well-established 
technique that can be performed with acceptable morbidity 
and mortality. Careful preoperative assessment of the 
extent of the disease is necessary to achieve a radical 
resection in healthy tissues leading to optimal local control 
of the disease [1, 2]. The size of the chest wall defect is 
related to postoperative complications and morbidity due 
to impaired respiratory fUnction and mechanics of the chest 
[3]. Therefore, the accuracy of preoperative determination 
of the extent of resection is crucial to achieve a complete 
resection without excessive morbidity. This is particularly 
important for large tumors that require extensive and 
sometimes complex resections [4]. 
Classically, preoperative radiological assessment of the 
extent of chest wall malignancies is performed with 
contrast-enhanced computed tomography (CT) or magnetic 
*Presented at the 15th European Conference on General Thoracic Surgery, 
Leuven, Belgium, June 3-6, 2007. 
1John O. Prior is the recipient of an Academic Research Award from the 
Leenaards Foundation (Lausanne, Switzerland). 
'Corresponding author. Tel.: +41 21 314 20 45 (business)/+ 41 79 613 61 
29 (home); fax: +41 21 314 23 58. 
E-mail address: david.petermann@bluewin.ch (D. Petermann). 
© 2009 Published by European Association for Cardia-Thoracic Surgery 
Downloaded from 
3 
resonance imaging (MRI) [5, 6]. Positron emission tomog-
raphy (PET) and its integration with CT imaging (PET /CT) 
is nowadays frequently applied to the staging, re-staging 
and follow-up of patients with neoplasms [7]. The role of 
PET in planning fulHhickness chest wall resection has never 
been analyzed. The purpose of this retrospective study was 
to evaluate the ability of PET in estimating tumor size of 
chest wall malignancies compared to classical morphologi-
cal CT imaging. 
2. Materials and methods 
2.1. Patient selection criteria 
We retrospectively evaluated consecutive patients who 
had full-thickness chest wall resection for malignancies 
performed at our institution from 2004 to 2006. After 
review of medical records, 18 patients had preoperative 
CT and PET imaging and were included (11 female and 7 
male patients, mean age 60±9 years, range 37-76). Resec-
tion indications were breast cancer recurrence (n = 10), 
chest wall metastasis (n = 6), primary chest wall sarcoma 
(n = 1) and desmoid tumor (n = 1). Our lnstitutional Ethics 
Committee approved this study and patient written consent 
was waived due toits retrospective nature. 
by on September 10, 2009 
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2.2. Pathotogy 
Directly after full-thickness chest wall resection, each 
surgical specimen was oriented spatially and sent to the 
pathology unit. Macroscopic and microscopie examinations 
were performed by one pathologist. Tumor localization was 
appreciated and the size of the tumor in the chest wall 
plane by approximating the shape of the tumor by an 
ellipse. lts two greatest perpendicular axes, defined as the 
a-axis and the b-axis , were measured. This 2-dimensional 
measurement method was chosen to reflect the area of 
chest wall resected in the operating room. As full-thickness 
resection was always performed, the depth of the tumor 
across the chest wall had no impact. The tumor relation to 
the resection margins was also examined. The tumor size 
derived from the surgical specimen served as the standard 
of reference used for comparison with tumor size obtained 
on PET and CT imaging. 
2.3. CT 
Morphological cross-sectional imaging was performed 
using an 8- or 16- multidetector CT unit (GE Medical 
Systems, Milwaukee, Wisconsin). After intravenous ( IV) 
iodinated contrast medium injection (Accupaque®, lohexol , 
Amersham Health AG , Waedenswil , Switzerland) axial slices 
in arterial phase were performed covering the region from 
the cervicothoracic inlet to the diaphragm ( 120 kV, 
120 mAs, pitch 1. 75 , slice reconstruction 2. 5 mm/ 2 mm). 
Two radiologists blinded to the PET and pathological find-
ings analyzed the CT images in consensus using multiplanar 
image reconstruction of the axial CT slices (Advantage 
Workstation , GEMS, Milwaukee) using the same definition 
for tumor size measurement on pathology (Figs. 1 and 2) . 
CT examinations were performed a median of 23 days 
Fig. 1. Method used for tumor size measurement. PET/ CT 3-D reconstruction 
of a tumor localized in the sternum and the left anterior part of the ch est 
wall (red). The two perpendicular greatest tumor extensions (a and b) were 
measured similarly on CT imaging and in histopathological assessment. 
Fig. 2. PET measurements in a 55 -year-old woman with chest wall invasion 
by a breast cancer recurrence (13.5 cm x 10. 7 cm , surface ~ 11 3 cm'). 
before the operation [interquartile range ( IQR) = 25th-75th 
percentile range = 2-41 days). 
2.4. PET 
Eleven patients were studied using a hybrid PET / CT 
system without contrast enhancement (Discovery LS, 
GEMS, Milwaukee) and seven patients were studied using a 
PET only system (Advance NXi , GEMS, Milwaukee). ln PET/ 
CT studies, the unenhanced CT was only used for attenua-
tion correction and not for CT measurements. Patients 
were instructed to fast > 6 h before the injection of 5 MBq/ 
kg of 18F-fluorodeoxyglucose (FDG). Two nuclear medicine 
physicians blinded to the CT and pathological findings 
analyzed PET only images in consensus with knowledge of 
clinicat history and previous radiological imaging study 
results . Multiplanar image reconstructions were used for 
image interpretation (Advantage Workstation , GEMS, Mil-
waukee). On PET images, an increase in FDG uptake above 
a standardized uptake value (SUV) of 2.0 g/ ml was used to 
define malignancy. The tumor size was measured on PET 
images by defining its two greatest perpendicular exten-
sions in the chest wall plane, with the same method as 
used by the pathologist (Figs. 1 and 2). PET examinations 
were performed a median of 31 ( IQR 13-34) days before 
the operation . 
2. 5. Surface ca/culation and statistical ana/ysis 
Bidimensional calculation of tumor surface was performed 
considering the tumor as an ellipse in the chest wall plane 
(surface of an ellipse S = 'TT [a/ 2] ·[b/ 2] = 'TT / 4·a ·b). Statistical 
analyses were performed using Stata 10.0 software (College 
Station, Texas) using non-parametric Wilcoxon-test, Lin's 
concordance correlation (a measure of bath precision and 
accuracy [8]) , and robust linear regression analysis to 
compare the tumor size measurements of the surgical 
specimen with the values obtained with PET and CT. Two-
tailed hypothesis testing was used. Robust multivariate 
analysis was performed to determine how well each imaging 
modality would predict the tumor surface. 
To investigate the possible clinical impact of PET in the 
planning of full -thickness chest wall resection , we assumed 
that more accurate determination of the tumor extent 
would be significant only for larger lesions. lndeed, for 
small resections, a more accurate determination of tumor 
extent by PET would not necessarily lead to a significantly 
Downloaded from icvts .ctsnetjournals.org by on September 10, 2009 
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different surgical excision than the one determined by CT. 
On the contrary, larger lesions would incur more extended 
surgery likely to include chest wall reconstruction and may 
benefit from the increased accuracy brought by PET. The 
optimal threshold was defined as the tumor surface meas-
ured on PET with the highest accuracy of PET to detect 
histopathology tumor extent. We determined the ability of 
each modality to determine if the tumor surface would be 
above this given threshold using receiver operating char-
acteristics (ROC) curves and areas under the curve (AUC), 
and computing the corresponding sensitivity, specificity and 
accuracy with standard formulas. 
3. Results 
The mean size of the chest wall defect after resection 
(measured on the surgical specimen) was 128 ± 94 cm 2 
(range 25-424 cm 2). Complete resection (RO) was achieved 
in 15 patients (83%) and 3 patients ( 17%) presented micro-
scopie infiltration (R1) of surgical margins (soft tissue 
infiltration in two patients and bony infiltration in one 
patient). The mean tumor surface measured by the pathol-
ogist on the surgical specimen was 40 ± 67 cm2 (range 
1-265 cm2), corresponding to a mean diameter of 7 cm or 
an ellipse of 6 x 8.5 cm (Table 1). 
3. 1. Comparison of PET and CT ta predict tumor extent 
Classical morphological cross-sectional imaging signifi-
cantly overestimated true tumor surface by 16 ± 35 cm 2 as 
compared to pathological measurements (P = 0.043). On 
the contrary, PET measurements overestimated tumor sur-
face by 9 ± 24 cm2 as compared to pathological findings, 
but the difference was not significant (P= 0.23). Fig. 3 
shows the Bland-Altman plots with the corresponding limits 
of agreement . Using robust linear regression, CT tended to 
significantly overestimate the tumor size by 64% [95% 
confidence interval (Cl) + 44 to + 90%] in average, while 
Table 1 
Tumor histology and surface measured on pathology, CT and PET 
n Age Sex Histology type 
(years) 
1 55 F Breast carcinoma 
2 60 F Breast carcinoma 
56 F Breast carcinoma 
4 51 F Breast carcinoma 
5 65 F Breast carcinoma 
6 64 F Breast carcinoma 
7 65 F Breast carcinoma 
8 56 F Breast carcinoma 
9 66 F Breast carcinoma 
10 62 F Breast carcinoma 
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Fig . 3. Bland-Altman plots showing the difference vs. mean for each meas-
urement pairs. Upper panel , CT measured surface vs. pathology surface. The 
mean difference of + 16 cm' (dashed line) was significantly different from 0 
(P= 0.043) . Lower panel , PET measured surface vs. pathology surface, with 
a mean difference of + 9 cm' (dashed line), not significantly different from 
0 (P = 0.23 ). Note the narrower 95% limits of agreement interval for PET as 
compared to CT (solid lines). 
PET was almost equal to histopathological size with a + 1% 
(95% Cl -13% to + 18%) overestimation in average (Fig. 4) . 
The concordance correlation coefficients between histo-
pathological tumor surface and CT (pc= 0.89, 95% Cl 0.83-
0.96) or PET (pc=0.95, 95% Cl 0.91-0.98) were excellent, 
with slightly higher values for PET, although the difference 
was not significant. ln multivariate robust linear regression, 
PET was a better predictor of tumor extension measured 
Surface measurement (cm') 
Pathology PET CT 
88.0 113 88 .7 
4.91 4.10 532.7 
6.16 5.72 o.oo· 
14.1 23.6 17.0 
1.18 13.2 42.4 
17.3 16.3 27.3 
18.9 44.6 38.5 
16.5 17.1 49.3 
7.07 17.7 22.6 
2.51 o.oo· 0.88 
11 72 M Thyroid carcinoma metastasis 18.9 17.2 28.9 
12 63 M Thyroid carcinoma metastasis 
13 66 M Parotid adenocarcinoma metastasis 
14 76 M Renal cell carcinoma metastasis 
15 68 M Esophageal adenocarcinoma metastasis 
16 37 M Mediastinal teratoma metastasis 
17 53 M Desmoid tumor 
18 49 F Chondrosarcoma 
•The tumor was not seen by this modality, but clinicat recurrence was suspected . 
CT, computed tomography; PET, positron emission tomography; F, female ; M, male. 
12.4 
9.35 
116 
9.82 
4.67 
265 
112 
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11.1 9.80 
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88.0 99.8 
18.0 12.5 
15.4 9.03 
356 398 
112 174 
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Fig. 4. Linear regression analysis of tumor surface on imaging vs. histopa-
thology. CT overestimates tumor surface by + 64% (slope 1.64, thick solid 
li ne), which was significantly more than when assessed by PET ( + 1 %, slope 
1.01, thin solid line) almost no different from the identity line (dotted line) . 
on the pathological specimen (13 = 0.61 , P < 0.001) than CT 
(13 = 0.23, P= 0.042), while the difference was not signifi-
cant (P=0.13), however. 
3.2 . Clinicat impact of PET 
The optimal threshold with the highest accuracy of PET 
to detect histopathology tumor extent was found to be 
about 24 cm 2 , equivalent to a diameter of 5. 5 cm or an 
ellipse of 4 x 7.6 cm. At this threshold, PET accuracy was 
maximized to reach 94%. The corresponding positive and 
negative predictive values, sensitivity and specificity, and 
likelihood ratios for PET and CT to predict a tumor diameter 
of > 5. 5 cm are given in Table 2. PET was significantly 
better than CT to determine the need for resection 
> 5. 5 cm, with a significantly better positive predictive 
value (80% vs. 44.4%), specificity and AUC on ROC analysis 
(Fig. 5) . 
4. Discussion 
Full -thickness resection of chest wall malignancies is cur-
rently performed in thoracic surgery units. Rewarding 
results can be obtained with acceptable morbidity even in 
the case of extended resections by use of synthetic substi-
tutes and of pediculized myocutaneous flaps [3, 4, 9-12]. 
The cornerstone for long-term disease-free survival is a 
complete resection and preoperative planning of the extent 
of resection is usually performed by CT or MRI. ln this 
retrospective study, we showed that PET-based measure-
ments of tumoral extent better correlated with histopath-
ological results than contrast-enhanced CT. ln addition, PET 
allowed a significantly better prediction of histopathologi-
cal results for large tumors > 5. 5 cm in diameter as com-
pared to enhanced CT. Thus, PET may be helpful in 
Table 2 
Ability of CT and PET for delineating lesions of > 5.5 cm in diameter 
CT measurement PET measurement P·value 
True positive 4 4 
True negative 9 13 
False positive 5 1 
False negative 0 0 
Sensitivity 100% 100% NS 
Specificity 64% 93% 0.011 
Accuracy 72% 94% < 0.001 
Positive predictive value 44% 80% < 0.001 
Negative predictive value 100% 100% NS 
AUC (ROC analysis) 0.82 0.96 0.026 
NS, not significant (P> 0.05); AUC, area under the curve; ROC , receiver 
operating characteristics. 
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Fig. 5. Recei ver operating characteristics (ROC) curves for CT (shaded area) 
and PET ta predict resections of > 5.5 cm in diameter using histopathology 
as gold standard (dashed line ~ reference line). The area under the curve 
(AUC) was significantly higher for PET as compared ta CT (P ~ 0.026) . 
complementing imaging for the planning of full-thickness 
chest wall resection for malignant disease. 
PET / CT imaging is routinely used in modern oncological 
patient care, allowing a more accurate staging of tumor 
than morphological cross-sectional imaging. PET / CT ena-
bles in one examination to assess the local tumor extension 
and the detection of distant metastasis. The utility of PET 
has been described in evaluating chest wall involvement of 
lung cancer [13], but its use in planning chest wall resection 
has not been reported. Similarly, several studies have 
described the utility of PET / CT for diagnosing breast cancer 
recurrence. For instance, Radan et al. reported that PET/ 
CT was superior to CT for the diagnosis of recurrence and 
the assessment of the extent of the disease [14]. lnterest-
ingly, Briccoli et al. have reported the superiority of ultra-
sonography to CT and MRI in determining soft tissue 
resection margins of malignant chest wall tumors [15] . ln 
their series of 22 patients, the authors obtained 100% of 
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complete resection and showed that ultrasonography was 
particularly useful in identifying micronodules, but this 
technique is not applicable for the examination of the 
chest wall per se. MRI is frequently performed for investi-
gation of tumors, particularly for osseous tumors. ln our 
institution, MRI is rarely performed for chest wall malig-
nancies because of the high quality of modern multidetec-
tor CT and the use of PET for local and distant staging of 
tumors. The role of MRI in this setting would need to be 
explored prospectively. 
A limitation of our study would be the variety of histolog-
ical types of the chest wall tumors, which may have had 
very different metabolic behaviors on PET. However, this 
heterogeneity reflects the daily clinicat care of patients 
with chest wall tumors undergoing resection and recon-
struction. Another limitation would be the retrospective 
design of our study. Thus, our promising results demonstrat-
ed the value of PET imaging for planning the extent of full-
thickness resection for chest wall tumors. This would need 
to be confirmed in a larger, prospective study, where the 
PET information would be systematically integrated in 
resection planning. Such a study would allow in addition to 
determine the impact of PET on RO, as well as on the long-
term outcome such as overall survival and recurrence rate. 
ln conclusion, our initial retrospective study suggests that 
PET might more accurately predict the extension of chest 
wall tumors than CT and would have a clinical impact in 
predicting the extent of required resections, especially in 
large tu mors ( > 5. 5 cm in diameter). However, prospective 
studies are needed to confirm these preliminary results and 
to determine the impact of delineating chest wall tumors 
by adding PET-derived information on tumor biology. 
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